Abstract
On October 22, 2020, the antiviral drug Remdesivir was approved by the United States Food and Drugs Authority (US FDA) for use in adults and pediatric patients for the treatment of COVID-19 requiring hospitalization. It was observed that Remdesivir and steroids have been used in treating moderate to severe COVID-19 patients. But there is very little evidence to justify which out of the two is a more rational approach towards treating patients infected with COVID-19 Disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
